Evidence map›Paper›PMID 31623578›Full record

GuidelineBMC nephrology2019

Renal Association Clinical Practice Guideline on Haemodialysis.

Damien Ashby, Natalie Borman, James Burton, Richard Corbett, Andrew Davenport, Ken Farrington, Katey Flowers, James Fotheringham, R N Andrea Fox, Gail Franklin and 15 more

Open access · goldAbstract readPractice Guideline
In one paragraph

Guideline in BMC nephrology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 122 papers, 14 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
122citing papers in PubMed, 14 pooled it
14.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

122 citing papers in PubMed, 14 syntheses or guidelines pooled it, 274 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Guideline
  6. Pooled it
  7. Pooled it
  8. Anticoagulation for people receiving long-term haemodialysis.The Cochrane database of systematic reviews · 2024
    Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Guideline
  14. Guideline
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

62 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 17 institutions in 2 countries.

Damien AshbyHammersmith Hospital, Imperial College Healthcare NHS Trust, London, England. melanie.dillon@renalregistry.nhs.uk.
Natalie BormanWessex Kidney Centre, Portsmouth NHS Trust, Portsmouth, England.
James BurtonUniversity Hospitals of Leicester NHS Trust, Leicester, England.
Richard CorbettHammersmith Hospital, Imperial College Healthcare NHS Trust, London, England.
Andrew DavenportRoyal Free London NHS Foundation Trust, London, UK.
Ken FarringtonLister Hospital, East & North Hertfordshire NHS Trust, Stevenage, England.
Katey FlowersWessex Kidney Centre, Portsmouth NHS Trust, Portsmouth, England.
James FotheringhamSheffield Teaching Hospitals NHS Foundation Trust, Sheffield, England.
R N Andrea FoxSchool of Nursing and Midwifery, University of Sheffield, Sheffield, England.
Gail FranklinEast & North Hertfordshire NHS Trust, Stevenage, England.
Claire GardinerLeeds Teaching Hospitals NHS Trust, Leeds, UK.
R N Martin GerrishUnited Lincolnshire Hospitals NHS Trust, Lincoln, UK.
Sharlene GreenwoodRenal and Exercise Rehabilitation, King's College Hospital, London, England.
Daljit HothiGreat Ormond Street Hospital, London, England.
Abdul KharesHaemodialysis Patient, c/o The Renal Association, Bristol, UK.
Pelagia KoufakiSchool of Health Sciences, Queen Margaret University, Edinburgh, Scotland.
Jeremy LevyHammersmith Hospital, Imperial College Healthcare NHS Trust, London, England.
Elizabeth LindleyDepartment of Renal Medicine, Leeds Teaching Hospitals NHS Trust, Leeds, England.
Jamie MacdonaldSchool of Sport, Health and Exercise Sciences, Bangor University, Bangor, UK.
Bruno MafriciNottingham University Hospitals NHS Trust, Nottingham, UK.
Andrew MooneyLeeds Teaching Hospitals NHS Trust, Leeds, UK.
James TattersallLeeds Teaching Hospitals NHS Trust, Leeds, UK.
Kay TyermanLeeds Teaching Hospitals NHS Trust, Leeds, UK.
Enric VillarLister Hospital, East & North Hertfordshire NHS Trust, Stevenage, England.
Martin WilkieSheffield Teaching Hospitals NHS Foundation Trust, Sheffield, England.
Leeds Teaching Hospitals NHS Trust · GBEast and North Hertfordshire NHS Trust · GBImperial College Healthcare NHS Trust · GBKidney Centre · PKSheffield Teaching Hospitals NHS Foundation Trust · GBBangor University · GBHammersmith Hospital · GBKing's College Hospital · GBLister Hospital · GBNottingham University Hospitals NHS Trust · GBQueen Margaret University · GBRenal Association · GBRoyal Free London NHS Foundation Trust · GBUnited Lincolnshire Hospitals NHS Trust · GBUniversity College London · GBUniversity Hospitals of Leicester NHS Trust · GBUniversity of Sheffield · GB

Funding

Department of Health CS-2013-13-014Department of Health DRF-2012-05-874Department of Health ICA-CL-2017-03-020
6 · The paper itself

Abstract

This guideline is written primarily for doctors and nurses working in dialysis units and related areas of medicine in the UK, and is an update of a previous version written in 2009. It aims to provide guidance on how to look after patients and how to run dialysis units, and provides standards which units should in general aim to achieve. We would not advise patients to interpret the guideline as a rulebook, but perhaps to answer the question: "what does good quality haemodialysis look like?"The guideline is split into sections: each begins with a few statements which are graded by strength (1 is a firm recommendation, 2 is more like a sensible suggestion), and the type of research available to back up the statement, ranging from A (good quality trials so we are pretty sure this is right) to D (more like the opinion of experts than known for sure). After the statements there is a short summary explaining why we think this, often including a discussion of some of the most helpful research. There is then a list of the most important medical articles so that you can read further if you want to - most of this is freely available online, at least in summary form.A few notes on the individual sections: 1. This section is about how much dialysis a patient should have. The effectiveness of dialysis varies between patients because of differences in body size and age etc., so different people need different amounts, and this section gives guidance on what defines "enough" dialysis and how to make sure each person is getting that. Quite a bit of this section is very technical, for example, the term "eKt/V" is often used: this is a calculation based on blood tests before and after dialysis, which measures the effectiveness of a single dialysis session in a particular patient. 2. This section deals with "non-standard" dialysis, which basically means anything other than 3 times per week. For example, a few people need 4 or more sessions per week to keep healthy, and some people are fine with only 2 sessions per week - this is usually people who are older, or those who have only just started dialysis. Special considerations for children and pregnant patients are also covered here. 3. This section deals with membranes (the type of "filter" used in the dialysis machine) and "HDF" (haemodiafiltration) which is a more complex kind of dialysis which some doctors think is better. Studies are still being done, but at the moment we think it's as good as but not better than regular dialysis. 4. This section deals with fluid removal during dialysis sessions: how to remove enough fluid without causing cramps and low blood pressure. Amongst other recommendations we advise close collaboration with patients over this. 5. This section deals with dialysate, which is the fluid used to "pull" toxins out of the blood (it is sometimes called the "bath"). The level of things like potassium in the dialysate is important, otherwise too much or too little may be removed. There is a section on dialysate buffer (bicarbonate) and also a section on phosphate, which occasionally needs to be added into the dialysate. 6. This section is about anticoagulation (blood thinning) which is needed to stop the circuit from clotting, but sometimes causes side effects. 7. This section is about certain safety aspects of dialysis, not seeking to replace well-established local protocols, but focussing on just a few where we thought some national-level guidance would be useful. 8. This section draws together a few aspects of dialysis which don't easily fit elsewhere, and which impact on how dialysis feels to patients, rather than the medical outcome, though of course these are linked. This is where home haemodialysis and exercise are covered. There is an appendix at the end which covers a few aspects in more detail, especially the mathematical ideas. Several aspects of dialysis are not included in this guideline since they are covered elsewhere, often because they are aspects which affect non-dialysis patients too. This includes: anaemia, calcium and bone health, high blood pressure, nutrition, infection control, vascular access, transplant planning, and when dialysis should be started.

Indexed as

Ambulatory Care FacilitiesAnticoagulantsDialysis SolutionsHumansMembranes, ArtificialRenal DialysisRenal InsufficiencyUnited KingdomAnticoagulantsDialysis SolutionsMembranes, Artificial

Identifiers

PMID31623578
PMCPMC6798406
OpenAlexW2980882742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.